Correction to: Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations.

Discussion" and had no impact on the conclusion hence the bottom of the table is removed.
PMID: 29149425 [PubMed - as supplied by publisher]

Source: International Journal of Hematology - November 17, 2017 Category: Hematology Authors: Nogami K, Shima M, Fukutake K, Fujii T, Taki M, Matsushita T, Higasa S, Sato T, Sakai M, Arai M, Uchikawa H, Engl W, Abbuehl B, Konkle BA Tags: Int J Hematol Source Type: research